SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001737287-22-000015
Filing Date
2022-02-23
Accepted
2022-02-23 16:20:18
Documents
5
Effectiveness Date
2022-02-23
Reference 429
333-253530

Document Format Files

Seq Description Document Type Size
1 S-8 allogene-formsx8x20220223.htm S-8 71468
2 EX-FILING FEES exhibit107-formsx8x2022022.htm EX-FILING FEES 23364
3 EX-5.1 exhibit51-formsx8x20220223.htm EX-5.1 8625
4 EX-23.1 exhibit231-formsx8x20220223.htm EX-23.1 2721
5 cooley.jpg GRAPHIC 10201
  Complete submission text file 0001737287-22-000015.txt   121355
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262923 | Film No.: 22663985
SIC: 2836 Biological Products, (No Diagnostic Substances)